This trial is active, not recruiting.

Condition nasal colonization with mrsa bacteria
Sponsor University of British Columbia
Start date October 2005
End date December 2012
Trial size 600 participants
Trial identifier NCT00247871, C05-0193


We plan to compare data from 300 nasal swab in Vancouver's Downtown Eastside taken in 2001 to data obtained in 2005. The nasal carriage rate of MRSA and the specific characteristic of each MRSA found will be analyzed. A limited amount of associated information will be obtained

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective retrospective

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: Patient had a microbiological sample submitted from the emergency department of the study hospital from 2001- 2005 which grew MRSA. Exclusion Criteria:

Additional Information

Official title The Prevalence of Panton Valentine Leukocidin, Exfoliative Toxin and Agr Genotypes in Staphylococcus Aureus Nasal Colonization in Vancouver's Eastside Community
Principal investigator Steve Reynolds, MD
Description MRSA samples will be characterized by pulse field gel electropheresis. An 9 item questionnaire will be administered.
Trial information was received from ClinicalTrials.gov and was last updated in September 2011.
Information provided to ClinicalTrials.gov by University of British Columbia.